Tag: NII
Scientists discover a new way to detect early colon cancer
A new collaborative study involving four institutes in India and one in France, and led by Dr. Sagar Sengupta at the National Institute of Immunology (NII), has discovered a new way that could identify the disease even at Stage I, the earliest stage............................
Nanoparticles-based improved cancer drug could be in the offing
A team of scientists in India has developed nanoparticles called nanomicelles that are extremely small in size ranging from 10 to 100 nanometers and they serve as efficient systems through which the drugs can be delivered......................
Study opens new avenue for preventing cancer
The scientists based at the National Institute of Immunology have found a way to stop the degradation of a protein called p53 that prevents cancer cells from proliferating and forming tumours in the body...................
Scientists find protein role in TB bacteria growth
Researchers at the National Institute of Immunology (NII) in collaboration with CSIR- Institute of Genomics and Integrative Biology (IGIB) have determined the role of FtsQ, a critical cell division protein that hampers growth and division patterns in Mycobacterium tuberculosis...……………….
Indian scientists testing dendritic therapy against cervix cancer
The therapeutic vaccine based on the antigen is being tested among 54 patients at Cancer Institute (WIA) at Adyar in Chennai...........
Indian scientists resurrect World War era drug to fight malaria
The researchers at Jawaharlal Nehru University have found that the acriflavine or ACF used as an anti-parasite drug during last century, is effective against malaria parasite and are, therefore working to make this molecule more effective using nanotechnology.........
Indian R&D efforts into health & environment all set to get...
Under the new arrangement, which was formally launched in the presence of the Minister for Science and Technology, Harsh Vardhan on June 19, India would become a scientific partner of ESRF through the RCB, Faridabad..............
Immunotherapy to tackle cancer, India tests first dendritic cell vaccine
Cancer antigen SPAG9 discovered at National Institute of Immunology after being tested successfully in the first phase of clinical trials, is now undergoing second phase of trials involving longer and detailed study.......